274 related articles for article (PubMed ID: 23731533)
1. The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands.
Eijgelshoven I; Demirdas S; Smith TA; van Loon JM; Latour S; Bosch AM
Mol Genet Metab; 2013 Jul; 109(3):237-42. PubMed ID: 23731533
[TBL] [Abstract][Full Text] [Related]
2. The personal burden for caregivers of children with phenylketonuria: A cross-sectional study investigating time burden and costs in the UK.
MacDonald A; Smith TA; de Silva S; Alam V; van Loon JM
Mol Genet Metab Rep; 2016 Dec; 9():1-5. PubMed ID: 27622144
[TBL] [Abstract][Full Text] [Related]
3. Household financial burden of phenylketonuria and its impact on treatment in China: a cross-sectional study.
Wang L; Zou H; Ye F; Wang K; Li X; Chen Z; Chen J; Han B; Yu W; He C; Shen M
J Inherit Metab Dis; 2017 May; 40(3):369-376. PubMed ID: 27832415
[TBL] [Abstract][Full Text] [Related]
4. Dietary patterns, cost and compliance with low-protein diet of phenylketonuria and other inherited metabolic diseases.
Mlčoch T; Puda R; Ješina P; Lhotáková M; Štěrbová Š; Doležal T
Eur J Clin Nutr; 2018 Jan; 72(1):87-92. PubMed ID: 28656971
[TBL] [Abstract][Full Text] [Related]
5. Mental health and social functioning in early treated Phenylketonuria: the PKU-COBESO study.
Jahja R; Huijbregts SC; de Sonneville LM; van der Meere JJ; Bosch AM; Hollak CE; Rubio-Gozalbo ME; Brouwers MC; Hofstede FC; de Vries MC; Janssen MC; van der Ploeg AT; Langendonk JG; van Spronsen FJ
Mol Genet Metab; 2013; 110 Suppl():S57-61. PubMed ID: 24183792
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study.
Demirdas S; Maurice-Stam H; Boelen CC; Hofstede FC; Janssen MC; Langendonk JG; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; de Vries M; Grootenhuis MA; Bosch AM
Mol Genet Metab; 2013; 110 Suppl():S49-56. PubMed ID: 24100246
[TBL] [Abstract][Full Text] [Related]
7. The effects of sapropterin on urinary monoamine metabolites in phenylketonuria.
Douglas TD; Jinnah HA; Bernhard D; Singh RH
Mol Genet Metab; 2013 Jul; 109(3):243-50. PubMed ID: 23712020
[TBL] [Abstract][Full Text] [Related]
8. The challenges of managing coexistent disorders with phenylketonuria: 30 cases.
MacDonald A; Ahring K; Almeida MF; Belanger-Quintana A; Blau N; Burlina A; Cleary M; Coskum T; Dokoupil K; Evans S; Feillet F; Giżewska M; Gokmen Ozel H; Lotz-Havla AS; Kamieńska E; Maillot F; Lammardo AM; Muntau AC; Puchwein-Schwepcke A; Robert M; Rocha JC; Santra S; Skeath R; Strączek K; Trefz FK; van Dam E; van Rijn M; van Spronsen F; Vijay S
Mol Genet Metab; 2015 Dec; 116(4):242-51. PubMed ID: 26498184
[TBL] [Abstract][Full Text] [Related]
9. Development of the US English version of the phenylketonuria - quality of life (PKU-QOL) questionnaire.
Jurecki E; Cunningham A; Birardi V; Gagol G; Acquadro C
Health Qual Life Outcomes; 2017 Mar; 15(1):46. PubMed ID: 28274259
[TBL] [Abstract][Full Text] [Related]
10. Stability of blood phenylalanine levels and IQ in children with phenylketonuria.
Anastasoaie V; Kurzius L; Forbes P; Waisbren S
Mol Genet Metab; 2008; 95(1-2):17-20. PubMed ID: 18703366
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries.
Bosch AM; Burlina A; Cunningham A; Bettiol E; Moreau-Stucker F; Koledova E; Benmedjahed K; Regnault A
Orphanet J Rare Dis; 2015 Jun; 10():80. PubMed ID: 26084935
[TBL] [Abstract][Full Text] [Related]
12. Outcomes beyond phenylalanine: an international perspective.
Feillet F; MacDonald A; Hartung Perron D; Burton B
Mol Genet Metab; 2010; 99 Suppl 1():S79-85. PubMed ID: 20123476
[TBL] [Abstract][Full Text] [Related]
13. Costs and outcomes over 36 years of patients with phenylketonuria who do and do not remain on a phenylalanine-restricted diet.
Guest JF; Bai JJ; Taylor RR; Sladkevicius E; Lee PJ; Lachmann RH
J Intellect Disabil Res; 2013 Jun; 57(6):567-79. PubMed ID: 22563770
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of comorbid conditions among adult patients diagnosed with phenylketonuria.
Burton BK; Jones KB; Cederbaum S; Rohr F; Waisbren S; Irwin DE; Kim G; Lilienstein J; Alvarez I; Jurecki E; Levy H
Mol Genet Metab; 2018 Nov; 125(3):228-234. PubMed ID: 30266197
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up and outcome of phenylketonuria patients on sapropterin: a retrospective study.
Keil S; Anjema K; van Spronsen FJ; Lambruschini N; Burlina A; Bélanger-Quintana A; Couce ML; Feillet F; Cerone R; Lotz-Havla AS; Muntau AC; Bosch AM; Meli CA; Billette de Villemeur T; Kern I; Riva E; Giovannini M; Damaj L; Leuzzi V; Blau N
Pediatrics; 2013 Jun; 131(6):e1881-8. PubMed ID: 23690520
[TBL] [Abstract][Full Text] [Related]
16. Relationships between lumbar bone mineral density and biochemical parameters in phenylketonuria patients.
de Groot MJ; Hoeksma M; van Rijn M; Slart RH; van Spronsen FJ
Mol Genet Metab; 2012 Apr; 105(4):566-70. PubMed ID: 22300845
[TBL] [Abstract][Full Text] [Related]
17. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Diamond A; Prevor MB; Callender G; Druin DP
Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
[TBL] [Abstract][Full Text] [Related]
18. Potential role of tetrahydrobiopterin in the treatment of maternal phenylketonuria.
Trefz FK; Blau N
Pediatrics; 2003 Dec; 112(6 Pt 2):1566-9. PubMed ID: 14654666
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and management practices for phenylketonuria in 19 countries of the South and Eastern European Region: survey results.
Giżewska M; MacDonald A; Bélanger-Quintana A; Burlina A; Cleary M; Coşkun T; Feillet F; Muntau AC; Trefz FK; van Spronsen FJ; Blau N
Eur J Pediatr; 2016 Feb; 175(2):261-72. PubMed ID: 26350228
[TBL] [Abstract][Full Text] [Related]
20. [The maternal phenylketonuria syndrom--still current problem].
Didycz B; Domagała L; Pietrzyk JJ
Przegl Lek; 2009; 66(1-2):4-10. PubMed ID: 19485248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
